Vimarsana
Biggest News Aggregation in the World

Insightec Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Insightec Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Insightec Ltd Today - Breaking & Trending Today

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR - Vimarsana News

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR

The Netherlands is the latest European country to recommend national coverage for the treatment of essential tremor with focused ultrasound.

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSEN - Vimarsana News

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSEN

The Netherlands is the latest European country to recommend national coverage for the treatment of essential...

 - Vimarsana News

The Netherlands is the latest European country to recommend national coverage for the treatment of essential tremor with focused ultrasound.

Source: ots.at
Insightec secures additional CE mark for Exablate Neuro to treat essential tremors - Vimarsana News

Insightec secures additional CE mark for Exablate Neuro to treat essential tremors

Insightec Ltd. broadened its CE mark approval for the Exablate Neuro, a focused ultrasound platform which treats essential tremors, to allow patients to have their second side treated. With some 60 million people estimated to be affected by essential tremor globally, Insightec hopes that with both sides treated, patients will have full body relief from tremor and therefore be able to resume everyday activities.

Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update - Vimarsana News

Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update

Strong start for Omisirge® launch with significant payer coverage and number of transplant centers onboarded exceeding expectations Company continues to pursue strategic partnership to further... -Today at 07:02 am- MarketScreener